Literature DB >> 27325775

Cardiac myosin light chain is phosphorylated by Ca2+/calmodulin-dependent and -independent kinase activities.

Audrey N Chang1, Pravin Mahajan2, Stefan Knapp3, Hannah Barton4, H Lee Sweeney5, Kristine E Kamm6, James T Stull6.   

Abstract

The well-known, muscle-specific smooth muscle myosin light chain kinase (MLCK) (smMLCK) and skeletal muscle MLCK (skMLCK) are dedicated protein kinases regulated by an autoregulatory segment C terminus of the catalytic core that blocks myosin regulatory light chain (RLC) binding and phosphorylation in the absence of Ca(2+)/calmodulin (CaM). Although it is known that a more recently discovered cardiac MLCK (cMLCK) is necessary for normal RLC phosphorylation in vivo and physiological cardiac performance, information on cMLCK biochemical properties are limited. We find that a fourth uncharacterized MLCK, MLCK4, is also expressed in cardiac muscle with high catalytic domain sequence similarity with other MLCKs but lacking an autoinhibitory segment. Its crystal structure shows the catalytic domain in its active conformation with a short C-terminal "pseudoregulatory helix" that cannot inhibit catalysis as a result of missing linker regions. MLCK4 has only Ca(2+)/CaM-independent activity with comparable Vmax and Km values for different RLCs. In contrast, the Vmax value of cMLCK is orders of magnitude lower than those of the other three MLCK family members, whereas its Km (RLC and ATP) and KCaM values are similar. In contrast to smMLCK and skMLCK, which lack activity in the absence of Ca(2+)/CaM, cMLCK has constitutive activity that is stimulated by Ca(2+)/CaM. Potential contributions of autoregulatory segment to cMLCK activity were analyzed with chimeras of skMLCK and cMLCK. The constitutive, low activity of cMLCK appears to be intrinsic to its catalytic core structure rather than an autoinhibitory segment. Thus, RLC phosphorylation in cardiac muscle may be regulated by two different protein kinases with distinct biochemical regulatory properties.

Entities:  

Keywords:  MLCK4; cMLCK; calcium/calmodulin; crystallography; kinase

Mesh:

Substances:

Year:  2016        PMID: 27325775      PMCID: PMC4941474          DOI: 10.1073/pnas.1600633113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  Substrate specificity of myosin light chain kinases.

Authors:  B P Herring; P J Gallagher; J T Stull
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

2.  Identification and function of neonatal Fc receptor in mammary gland of lactating mice.

Authors:  P Cianga; C Medesan; J A Richardson; V Ghetie; E S Ward
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

3.  Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease.

Authors:  Farah Sheikh; Kunfu Ouyang; Stuart G Campbell; Robert C Lyon; Joyce Chuang; Dan Fitzsimons; Jared Tangney; Carlos G Hidalgo; Charles S Chung; Hongqiang Cheng; Nancy D Dalton; Yusu Gu; Hideko Kasahara; Majid Ghassemian; Jeffrey H Omens; Kirk L Peterson; Henk L Granzier; Richard L Moss; Andrew D McCulloch; Ju Chen
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

4.  Beneficial effects of SR33805 in failing myocardium.

Authors:  Younss Ait Mou; Attila Toth; Cécile Cassan; Daniel Czuriga; Pieter P de Tombe; Zoltan Papp; Alain Lacampagne; Olivier Cazorla
Journal:  Cardiovasc Res       Date:  2011-04-04       Impact factor: 10.787

5.  Myosin light chain phosphorylation is critical for adaptation to cardiac stress.

Authors:  Sonisha A Warren; Laura E Briggs; Huadong Zeng; Joyce Chuang; Eileen I Chang; Ryota Terada; Moyi Li; Maurice S Swanson; Stewart H Lecker; Monte S Willis; Francis G Spinale; Julie Maupin-Furlowe; Julie R McMullen; Richard L Moss; Hideko Kasahara
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

6.  Myosin regulatory light chain phosphorylation attenuates cardiac hypertrophy.

Authors:  Jian Huang; John M Shelton; James A Richardson; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

7.  Signaling processes for initiating smooth muscle contraction upon neural stimulation.

Authors:  Hai-Lei Ding; Jeffrey W Ryder; James T Stull; Kristine E Kamm
Journal:  J Biol Chem       Date:  2009-04-06       Impact factor: 5.157

8.  Neutron-scattering studies reveal further details of the Ca2+/calmodulin-dependent activation mechanism of myosin light chain kinase.

Authors:  J K Krueger; G Zhi; J T Stull; J Trewhella
Journal:  Biochemistry       Date:  1998-10-06       Impact factor: 3.162

9.  The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.

Authors:  J van der Velden; Z Papp; N M Boontje; R Zaremba; J W de Jong; P M L Janssen; G Hasenfuss; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

10.  Enhanced skeletal muscle contraction with myosin light chain phosphorylation by a calmodulin-sensing kinase.

Authors:  Jeffrey W Ryder; Kim S Lau; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2007-05-15       Impact factor: 5.157

View more
  18 in total

Review 1.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

2.  Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain.

Authors:  Sunil Yadav; Katarzyna Kazmierczak; Jingsheng Liang; Yoel H Sitbon; Danuta Szczesna-Cordary
Journal:  FEBS J       Date:  2018-12-01       Impact factor: 5.542

Review 3.  Role of myosin light chain phosphatase in cardiac physiology and pathophysiology.

Authors:  Audrey N Chang; Kristine E Kamm; James T Stull
Journal:  J Mol Cell Cardiol       Date:  2016-10-11       Impact factor: 5.000

Review 4.  Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology.

Authors:  Masaaki Ito; Ryuji Okamoto; Hiromasa Ito; Ye Zhe; Kaoru Dohi
Journal:  Hypertens Res       Date:  2021-10-06       Impact factor: 3.872

5.  NIMA-related kinase 9 regulates the phosphorylation of the essential myosin light chain in the heart.

Authors:  Marion Müller; Rose Eghbalian; Jes-Niels Boeckel; Karen S Frese; Jan Haas; Elham Kayvanpour; Farbod Sedaghat-Hamedani; Maximilian K Lackner; Oguz F Tugrul; Thomas Ruppert; Rewati Tappu; Diana Martins Bordalo; Jasmin M Kneuer; Annika Piekarek; Sabine Herch; Sarah Schudy; Andreas Keller; Nadja Grammes; Cornelius Bischof; Anna Klinke; Margarida Cardoso-Moreira; Henrik Kaessmann; Hugo A Katus; Norbert Frey; Lars M Steinmetz; Benjamin Meder
Journal:  Nat Commun       Date:  2022-10-20       Impact factor: 17.694

6.  The dominant protein phosphatase PP1c isoform in smooth muscle cells, PP1cβ, is essential for smooth muscle contraction.

Authors:  Audrey N Chang; Ning Gao; Zhenan Liu; Jian Huang; Angus C Nairn; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2018-09-05       Impact factor: 5.157

7.  Therapeutic potential of AAV9-S15D-RLC gene delivery in humanized MYL2 mouse model of HCM.

Authors:  Sunil Yadav; Chen-Ching Yuan; Katarzyna Kazmierczak; Jingsheng Liang; Wenrui Huang; Lauro M Takeuchi; Rosemeire M Kanashiro-Takeuchi; Danuta Szczesna-Cordary
Journal:  J Mol Med (Berl)       Date:  2019-05-17       Impact factor: 4.599

8.  Increasing evidence of mechanical force as a functional regulator in smooth muscle myosin light chain kinase.

Authors:  Fabian Baumann; Magnus Sebastian Bauer; Martin Rees; Alexander Alexandrovich; Mathias Gautel; Diana Angela Pippig; Hermann Eduard Gaub
Journal:  Elife       Date:  2017-07-11       Impact factor: 8.140

Review 9.  Myosin Light Chain Kinase: A Potential Target for Treatment of Inflammatory Diseases.

Authors:  Yongjian Xiong; Chenou Wang; Liqiang Shi; Liang Wang; Zijuan Zhou; Dapeng Chen; Jingyu Wang; Huishu Guo
Journal:  Front Pharmacol       Date:  2017-05-23       Impact factor: 5.810

10.  The myosin light-chain kinase MLCK-1 relocalizes during Caenorhabditis elegans ovulation to promote actomyosin bundle assembly and drive contraction.

Authors:  Charlotte A Kelley; Alison C E Wirshing; Ronen Zaidel-Bar; Erin J Cram
Journal:  Mol Biol Cell       Date:  2018-04-05       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.